Outcomes of adults with relapsed or refractory Burkitt and high-grade B-cell leukemia/lymphoma-Reference-Cited by-同舟云学术

Outcomes of adults with relapsed or refractory Burkitt and high-grade B-cell leukemia/lymphoma

Published:2017-04-18 Issue:6 Volume:92 Page:E114-E117
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Short Nicholas J.¹^ORCID,Kantarjian Hagop M.²^ORCID,Ko Heidi³,Khoury Joseph D.⁴,Ravandi Farhad²,Thomas Deborah A.²,Garcia-Manero Guillermo²,Khouri Maria²,Cortes Jorge E.²,Wierda William G.²,Verstovsek Srdan²,Estrov Zeev²,Ferrajoli Alessandra²,Thompson Philip A.²,Pierce Sherry²,O'Brien Susan M.⁵,Jabbour Elias²^ORCID

Affiliation:

1. Division of Cancer Medicine; The University of Texas MD Anderson Cancer Center; Houston Texas USA

2. Department of Leukemia; The University of Texas MD Anderson Cancer Center; Houston Texas USA

3. Department of Internal Medicine; The University of Texas Health Science Center; Houston Texas USA

4. Department of Hematopathology; The University of Texas Health Science Center; Houston Texas USA

5. Chao Family Comprehensive Cancer Center, University of California Irvine; Orange California USA

Funder

MD Anderson Cancer Center Support

Publisher

Wiley

Subject

Hematology

Reference10 articles.

1. Burkitt's lymphoma: clinicopathologic features and differential diagnosis;Ferry;Oncologist.,2006

2. Burkitt lymphoma and atypical Burkitt or Burkitt-like lymphoma: should these be treated as different diseases?;Thomas;Curr Hematol Malign Rep.,2011

3. The 2016 revision of the World Health Organization classification of lymphoid neoplasms;Swerdlow;Blood.,2016

4. Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia;Thomas;Cancer.,2006

5. Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial;Ribrag;Lancet.,2016

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the Antitumor Activity of Omipalisib, a PI3K/AKT/MTOR Pathway Inhibitor, on Burkitt Lymphoma Cell Line;Cumhuriyet Science Journal;2023-12-28

2. Chemotherapy resistant Burkitt lymphoma: Possible novel therapies including CAR‐T cell infusion;Clinical Case Reports;2023-05-29

3. EBV and Lymphomagenesis;Cancers;2023-04-04

4. The RNA helicase DDX3 and its role in c-MYC driven germinal center-derived B-cell lymphoma;Frontiers in Oncology;2023-03-24

5. Polatuzumab Vedotin in a Patient with Refractory Burkitt Lymphoma, a Case Report;OncoTargets and Therapy;2023-02